Abstract:Summary Background Research in healthy young adults shows that characteristic patterns of brain activity define individual "brain-fingerprints" that are unique to each person. However, variability in these brain-fingerprints increases in individuals with neurological conditions, challenging the clinical relevance and potential impact of the approach. Our study shows that brain-fingerprints derived from neurophysiological brain activity are associated with pathophysiological and clinical traits of individual patients with Parkinson's disease (PD). Methods We created brain-fingerprints from task-free brain activity recorded through magnetoencephalography in 79 PD patients and compared them with those from two independent samples of age-matched healthy controls (N = 424 total). We decomposed brain activity into arrhythmic and rhythmic components, defining distinct brain-fingerprints for each type from recording durations of up to 4 min and as short as 30 s. Findings The arrhythmic spectral components of cortical activity in patients with Parkinson's disease are more variable over short periods, challenging the definition of a reliable brain-fingerprint. However, by isolating the rhythmic components of cortical activity, we derived brain-fingerprints that distinguished between patients and healthy controls with about 90% accuracy. The most prominent cortical features of the resulting Parkinson's brain-fingerprint are mapped to polyrhythmic activity in unimodal sensorimotor regions. Leveraging these features, we also demonstrate that Parkinson's symptom laterality can be decoded directly from cortical neurophysiological activity. Furthermore, our study reveals that the cortical topography of the Parkinson's brain-fingerprint aligns with that of neurotransmitter systems affected by the disease's pathophysiology. Interpretation The increased moment-to-moment variability of arrhythmic brain-fingerprints challenges patient differentiation and explains previously published results. We outline patient-specific rhythmic brain signaling features that provide insights into both the neurophysiological signature and symptom laterality of Parkinson's disease. Thus, the proposed definition of a rhythmic brain-fingerprint of Parkinson's disease may contribute to novel, refined approaches to patient stratification. Symmetrically, we discuss how rhythmic brain-fingerprints may contribute to the improved identification and testing of therapeutic neurostimulation targets. Funding Data collection and sharing for this project was provided by the Quebec Parkinson Network (QPN), the Pre-symptomatic Evaluation of Novel or Experimental Treatments for Alzheimer's Disease (PREVENT-AD; release 6.0) program, the Cambridge Centre for Aging Neuroscience (Cam-CAN), and the Open MEG Archives (OMEGA). The QPN is funded by a grant from Fonds de Recherche du Québec - Santé (FRQS). PREVENT-AD was launched in 2011 as a $13.5 million, 7-year public-private partnership using funds provided by McGill University , the FRQS, an unrestricted research grant from Pfizer Canada , the Levesque Foundation , the Douglas Hospital Research Centre and Foundation , the Government of Canada , and the Canada Fund for Innovation . The Brainstorm project is supported by funding to SB from the NIH ( R01-EB026299-05 ). Further funding to SB for this study included a Discovery grant from the Natural Sciences and Engineering Research Council of Canada of Canada ( 436355-13 ), and the CIHR Canada research Chair in Neural Dynamics of Brain Systems ( CRC-2017-00311 ).

Capturing Trial-by-Trial Variability in Behaviour: People with Parkinson's Disease Exhibit a Greater Rate of Short-Term Fluctuations in Response Times

Lower theta inter-trial phase coherence during performance monitoring is related to higher reaction time variability: A lifespan study

Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models

Variance (un)explained: Experimental conditions and temporal dependencies explain similarly small proportions of reaction time variability in linear models of perceptual and cognitive tasks

Naturalistic assessment of reaction time variability in older adults at risk for Alzheimer's disease

MRI Assessment of Intrinsic Neural Timescale and Gray Matter Volume in Parkinson's Disease

Cortical effects of dopamine replacement account for clinical response variability in Parkinson's disease

The Cumulative Effect of Transient Synchrony States on Motor Performance in Parkinson's Disease

The Low-Frequency Fluctuation of Trial-by-Trial Frontal Theta Activity and Its Correlation With Reaction-Time Variability in Sustained Attention

Differential Temporal Perception Abilities in Parkinson’s Disease Patients Based on Timing Magnitude

The neurophysiological brain-fingerprint of Parkinson's disease

Changes in electrophysiological aperiodic activity during cognitive control in Parkinson's disease

Average Is Optimal: An Inverted-U Relationship between Trial-to-Trial Brain Activity and Behavioral Performance

Impacts on study design when implementing digital measures in Parkinson's disease-modifying therapy trials

Dysrhythmia as a prominent feature of Parkinson's disease: An app-based tapping test

Rapid motor fluctuations reveal short-timescale neurophysiological biomarkers of Parkinson’s disease

Amplitude of Low-frequency Oscillations in Parkinson's Disease

Multiple Modes of Impulsivity in Parkinson's Disease.

β band stability over time correlates with Parkinsonian rigidity and bradykinesia

L-Dopa induced changes in aperiodic bursts dynamics relate to individual clinical improvement in Parkinson's disease

Study of EEG microstates in Parkinson's disease: a potential biomarker?